van den Hof S - Search Results

1

Evidence-based interventions to reduce tuberculosis stigma: a systematic review.

Sommerland N, Wouters E, Mitchell EMH, Ngicho M, Redwood L, Masquillier C, van Hoorn R, van den Hof S, Van Rie A. Sommerland N, et al. Among authors: van hoorn r, van den hof s, van rie a. Int J Tuberc Lung Dis. 2017 Nov 1;21(11):81-86. doi: 10.5588/ijtld.16.0788. Int J Tuberc Lung Dis. 2017. PMID: 29025489 Review.

2

Integration of HIV testing in tuberculosis drug resistance surveillance in Kazakhstan and Kenya.

Klinkenberg E, van den Hof S, Tursynbayeva A, Kipruto H, Wahogo J, Pak S, Kutwa A, L'Herminez R. Klinkenberg E, et al. Among authors: van den hof s. Int J Tuberc Lung Dis. 2012 May;16(5):615-7. doi: 10.5588/ijtld.11.0262. Epub 2012 Mar 8. Int J Tuberc Lung Dis. 2012. PMID: 22409816

3

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S. van den Hof S, et al. Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703. Int J Tuberc Lung Dis. 2013. PMID: 23485387

4

Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.

Erkens CG, Dinmohamed AG, Kamphorst M, Toumanian S, van Nispen-Dobrescu R, Alink M, Oudshoorn N, Mensen M, van den Hof S, Borgdorff M, Verver S. Erkens CG, et al. Among authors: van nispen dobrescu r, van den hof s. Int J Tuberc Lung Dis. 2014 Apr;18(4):413-20. doi: 10.5588/ijtld.13.0589. Int J Tuberc Lung Dis. 2014. PMID: 24670695

5

Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.

van Altena R, de Vries G, Haar CH, de Lange WC, Magis-Escurra C, van den Hof S, van Soolingen D, Boeree MJ, van der Werf TS. van Altena R, et al. Among authors: van der werf ts, van soolingen d, van den hof s. Int J Tuberc Lung Dis. 2015 Apr;19(4):406-12. doi: 10.5588/ijtld.14.0838. Int J Tuberc Lung Dis. 2015. PMID: 25859995

6

Elevated mortality after successful tuberculosis treatment.

van den Hof S, Borgdorff MW. van den Hof S, et al. Int J Tuberc Lung Dis. 2016 Jan;20(1):2. doi: 10.5588/ijtld.15.0652. Int J Tuberc Lung Dis. 2016. PMID: 26688521 Free PMC article. No abstract available.

7

Using existing data to illustrate--and close--the gap in access to new anti-tuberculosis drugs.

Mitnick C, van den Hof S. Mitnick C, et al. Among authors: van den hof s. Int J Tuberc Lung Dis. 2016 Feb;20(2):145. doi: 10.5588/ijtld.15.0911. Int J Tuberc Lung Dis. 2016. PMID: 26792461 No abstract available.

8

No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.

Cobelens F, Gebhard A, van den Hof S. Cobelens F, et al. Among authors: van den hof s. Int J Tuberc Lung Dis. 2016 Feb;20(2):282. doi: 10.5588/ijtld.15.0628. Int J Tuberc Lung Dis. 2016. PMID: 26792486 No abstract available.

9

Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil.

Pinto M, Steffen RE, Cobelens F, van den Hof S, Entringer A, Trajman A. Pinto M, et al. Among authors: van den hof s. Int J Tuberc Lung Dis. 2016 May;20(5):611-8. doi: 10.5588/ijtld.15.0455. Int J Tuberc Lung Dis. 2016. PMID: 27084814

10

The Effects of Psycho-Emotional and Socio-Economic Support for Tuberculosis Patients on Treatment Adherence and Treatment Outcomes - A Systematic Review and Meta-Analysis.

van Hoorn R, Jaramillo E, Collins D, Gebhard A, van den Hof S. van Hoorn R, et al. Among authors: van den hof s. PLoS One. 2016 Apr 28;11(4):e0154095. doi: 10.1371/journal.pone.0154095. eCollection 2016. PLoS One. 2016. PMID: 27123848 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters